Yanning Liu

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia

Joris Berwaerts, Yanning Liu, Srihari Gopal et al. · JAMA Psychiatry · 2015 · 224 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study

Michelle Kramer, Robert E. Litman, David Hough et al. · The International Journal of Neuropsychopharmacology · 2009 · 178 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

Danielle Coppola, Yanning Liu, Srihari Gopal et al. · BMC Psychiatry · 2012 · 60 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Relapse prevention study of paliperidone extended-release tablets in Chinese patients with schizophrenia

Qing Rui, Yang Wang, Liang Shu et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2014 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

One-Year Open-Label Safety and Efficacy Study of Paliperidone Extended-Release Tablets in Patients With Schizophrenia

Michelle Kramer, George M. Simpson, Valentinas Mačiulis et al. · CNS Spectrums · 2010 · 29 citations

Pharmacy, Pharmacology, Pharmacotherapy +17